Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

A study by DKFZ researchers shows that inhibiting the enzyme aldolase A in glycolysis traps energy in liver cancer cells, ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

Silexion Therapeutics Corp. (NASDAQ:SLXN) released new preclinical data for SIL-204, its next-generation siRNA therapeutic ...

Glycolysis is an important sugar degradation pathway that cancer cells in particular depend on. Scientists at the German Cancer Research Center (DKFZ) have now shown that liver cancer cells in mice ...

blocks tumor growth in mice. Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a lid on their growth? Previous studies showed ...

The therapy performed well in mice, activating tumor suppressor genes and impairing tumor growth. Because UHFR1 is implicated ... Defining ortholog-specific UHRF1 inhibition by STELLA for cancer ...

Silexion Therapeutics (SLXN) announced new preclinical data for SIL-204, its next-generation siRNA therapeutic candidate. The findings ...

The therapy performed well in mice, activating tumor suppressor genes and impairing tumor growth. Because UHFR1 ... Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy ...